Controls glycaemic spikes, reducing lipid accumulation and the feeling of hunger
Libramed is a medical device that has been clinically tested for safety and efficacy in the treatment of excess weight and obesity. Aids the reduction of body weight and waistline.
INDICATIONS
Libramed's mechanism of action make it suitable for:
Adults
- who are overweight or obese
- with a large waist circumference, even if weight is normal
Children from 8 years of age
- who are overweight or obese
The product achieves maximum effectiveness when combined with a balanced diet, sufficient fluid intake and regular physical exercise.
Libramed controls spikes in glycaemia levels after meals, ensuring constant blood glucose and insulin levels, thereby reducing lipogenesis (accumulation of fat in lipocytes) and the feeling of hunger.
Libramed's action is due to Policaptil Gel Retard®, a patented complex of polysaccharide macro-molecules containing components working synergistically to create a strong gelifying action. Policaptil forms a gel in the bowel reducing the quantity and rate at which carbohydrates are absorbed (retard effect).
Thanks to the properties of this gel, Libramed also limits the absorption of lipids, reducing postprandial sleepiness, while aiding bowel transit and regulating the consistency of stools.
ADMINISTRATION
Adults and children over the age of 12 | 3 tablets before lunch and dinner |
Children aged between 8 and 12 | 2 tablets before lunch and dinner |
The dose should be taken with a large glass of water, swallowing one tablet at a time. Do not chew or bite the tablets.
For those who have difficulty swallowing, the Libramed tablets can be stirred into warm water or unsweetened herbal tea until completely dissolved. This drink should be taken within a few minutes, before formation of the gel.
Additional information
Weight | 138 kg |
---|